News &
Publications

Contacts

Franklin Hoke
Vice President
for Communications
215-728-2700
215-475-2888 (cell phone)
Franklin.Hoke@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Fox Chase Cancer Center's Sigurdson Promoted to Senior Member

PHILADELPHIA(October 23, 2000) -- Dr. Elin R. Sigurdson of xx, PA, has been promoted to senior member in the Department of Surgical Oncology at Fox Chase Cancer Center.

Sigurdson is the director of surgical research and is a pioneer in the use of sentinel lymph node biopsy, which spares breast cancer patients of unnecessary surgery. Also successful for melamona, lymphatic mapping allows surgeons to identify the first, or sentinel, node which is then to determine whether cancer has spread. If negative, no other nodes need to be removed allowing patients to avoid complications due to removal such as lymphedema.

Dr. Sigurdson is a graduate of the University of Toronto Medical School, Toronto, Ontario, Canada, where she was an intern and a resident in general surgery. She later became a research and clinical fellow at Memorial Sloan-Kettering in New York City. She is an Associate Professor of Surgery at Temple University Medical School.

Board certified by the Royal College of Surgeons (Canada) she is also certified by the American College of Surgery. Dr. Sigurdson holds memberships in many professional societies, including the American Radium Society, Radiation Therapy Oncology Group, Association of Women Surgeons, Society of Surgical Oncology, and the American Society of Colon and Rectal surgeons, among others.

Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

More 2000 News Releases »